Respiratory syncytial virus inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708332
SERIAL NO

15032855

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula (I), wherein R1, R2, R3, R4 and n are defined herein, are useful as inhibitors of RSV.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIVIR ABLUNASTIGEN 7 S-141 44 HUDDINGE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brochu, Christian Burlington, CA 58 1790
Decor, Anne Burlington, CA 35 85
Deroy, Patrick Burlington, CA 13 118
Duplessis, Martin Burlington, CA 40 231
Grand-Maitre, Chantal Burlington, CA 11 13
Halmos, Teddy Burlington, CA 36 1514
Jakalian, Araz Burlington, CA 6 15
Kuhn, Cyrille Ridgefield, US 8 8
Morency, Louis Burlington, CA 4 43
Sturino, Claudio Burlington, CA 39 195
Tremblay, Martin Burlington, CA 40 984

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00